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Összefoglalás 
A perinatális aszfixia a csecsemő halálát, vagy a központi idegrendszer (KIR) 
maradandó károsodását: ún. hipoxiás-iszkémiás enkefalopátiát (HIE) okozhat.  A HIE évente, 
világszerte mintegy egymillió csecsemőt érint, de súlyos társadalmi és gazdasági 
következményei ellenére, az első klinikailag igazolt neuroprotektív terápia, - a mérsékelt 
teljes test hipotermia - csak az elmúlt években került szélesebb körben alkalmazásra.  Az 
aszfixiás újszülött újraélesztése szinte valamennyi esetben a lélegeztetés megindításával 
kezdődik, ezért a lélegeztetésre felhasznált gázkeverékbe kevert, neuroprotektív hatású gázok 
a károsodásokat önmagukban is mérsékelhetnék, a hipotermiával kombinálva pedig 
fokozhatnák annak hatékonyságát.  Például a molekuláris hidrogén ideális terápiás szer 
lehetne hidroxil és peroxinitrit gyökökre szelektív antioxidáns tulajdonságánál fogva.  
A HIE vizsgálatára több állatkísérletes modell áll rendelkezésre.  Szegedi 
laboratóriumunkban a HIE vizsgálatára elfogadott girenkefál fajt, az újszülött malacot 
alkalmaztuk.  A HIE patomechanizmusában jelentős szerepet játszhat az ún. neurovaszkuláris 
egység funkciókárosodása, mely felelős a neuronok metabolikus igényeinek biztosításáért.  
Ezért a molekuláris hidrogén neuroprotektív hatásának elemzéséhez a neuropatológiai 
vizsgálatok mellett a neurovaszkuláris egység integritását jelző stimulusokkal szembeni 
cerebrovaszkuláris reaktivitást (CR) határoztuk meg mind az inzultust követő túlélés akut (1-4 
óra, n=31) és szubakut (24 óra, n=27) fázisában.  Új kísérleti eredményeink közül kiemelendő 
az a korábban nem ismert jelenség, hogy aszfixiát követően a neurovaszkuláris diszfunkció 
átmeneti javulás után újra súlyosan károsodik a szubakut időszakban.  A molekuláris 
hidrogén, noha önmagában nem befolyásolja a CR-t ill. az agykérgi véráramlást, azonban 
aszfixiát követően egyaránt mérsékli mind a neurovaszkuláris egység funkciójának, mind a 
KIR idegsejtjeinek károsodását. 
Eredményeink összhangban vannak a hidrogén antioxidáns hatásmechanizmusával, 
hiszen a neurovaszkuláris egység károsodásáért jelentős részben a reoxigenizációs periódus 
során megnövekedett reaktív oxigéngyök termelődés felelős.  Eredményeink arra 
isrámutatnak, hogy az aszfixiát követő korai reoxigenizációs periódusban alkalmazott 
molekuláris hidrogén nemcsak rövid, hanem hosszabb távon is képes javítani a neuronális-
vaszkuláris funkciót, továbbá felveti további preklinikai vizsgálatok szükségességét.  A 
molekuláris hidrogén további vizsgálatának jogosultságát alátámasztja egyszerű 
előállíthatósága, adagolhatósága és kedvező farmakokinetikai tulajdonságai. 
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Summary 
Perinatal asphyxia can elicit mortality or severe disability in the survivors called 
hypoxic-ischemic encephalopathy (HIE) in term infants.  HIE yearly affects around one 
million babies worldwide.  In contrast to the severe impact of HIE on the society and on the 
health care budget, the first effective neuroprotective therapy, mild whole-body hypothermia, 
has only recently been introduced into broader clinical practice.  The resuscitation efforts in 
asphyxiated infants start invariably with adequate mechanical ventilation.  The gas mixture 
used for artificial ventilation could be used to deliver possibly neuroprotective gases to reduce 
CNS damage, and to perhaps augment the efficacy of hypothermia.  For instance, molecular 
hydrogen could be an ideal therapeutic agent, as it has recently been shown to exert selective 
antioxidant properties against hydroxyl and peroxynitrite radicals. 
There are several animal models to study HIE pathology.. In our Szeged laboratory, a 
widely-used gyrencephalic large animal model of HIE, the newborn piglet has been utilized.  
Dysfunction of the so-called neurovascular unit – that is responsible for meeting the metabolic 
demands of neurons – may play an important role in the pathomechanism of HIE.  Therefore, 
to assess the putative neuroprotective effects of molecular hydrogen, beside neuropathology 
we also determined CR to stimuli indicating neurovascular unit integrity both in the acute (1-4 
h, n=31) and the subacute (24 h, n=27) phase of survival after asphyxia.  We would like to 
highlight the novel observation from our results that after an initial recovery at the end of the 
acute period, a second delayed neurovascular unit dysfunction develops in the subacute phase.  
The molecular hydrogen gas per se did not affect CR or cortical perfusion, but preserved 
neurovascular unit function and diminished neuronal damage in the CNS after asphyxia.  
Our results are in accordance with the antioxidant mechanism of molecular hydrogen 
actions, since neurovascular unit dysfunction has been previously shown to be triggered by 
elevated levels of reactive oxygen species during reoxygenation.  Our data suggest that 
molecular hydrogen administered in the early reoxygenation can alleviate not only the acute 
but also the delayed phase of neurovascular dysfunction demanding further preclinical 
research.  The importance of further research on molecular hydrogen is also substantiated by 
its other appealing features concerning its medical use: it is inexpensive, simple to produce 
and to administer, and has ideal pharmacokinetics. 
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Introduction 
 
Hypoxic-ischemic encephalopathy 
Perinatal asphyxia, more appropriately the subsequently developing hypoxic-ischemic 
encephalopathy (HIE) is a severe condition in neonatology, which can cause significant 
mortality and long-term morbidity.  HIE is characterized by clinical and laboratory evidence 
of brain injury caused by asphyxia.  Despite the recent technical developments in monitoring 
technologies, most often the exact timing and the underlying cause of HIE remains unknown.  
The most common primary physiological processes that lead to brain hypoxia and ischemia, 
thus causes HIE are systemic hypoxemia/hypercapnia, and/or reduced cerebral blood flow 
(CBF) [1-3].  
In most developed countries, the incidence of severe perinatal asphyxia and the 
subsequent HIE is around 1-8 cases per 1000 births.  The incidence of HIE in countries with 
limited resources is higher, however precise numbers and figures are not available.  Birth 
asphyxia is responsible for 23% of all neonatal deaths worldwide, and taking into 
consideration its 8% contribution of the yearly 10.6 million deaths of children younger than 
five years, HIE is the fifth largest cause of death in this age group [4, 5].  Aside from the 
significant responsibility in pediatric mortality, more than a million children surviving birth 
asphyxia will suffer from cerebral palsy, mental retardation, epilepsy, learning difficulties, 
and other disabilities [6].  
The preconceptual and antepartum risk factors of HIE are still unclear, although it seems 
that insulin-dependent diabetes mellitus, thyroid disease, fertility treatments, severe 
preeclampsia, placental abruption and intrauterine growth restriction may have significant 
impact on the incidence of birth asphyxia.  The intrapartum events, such as cord prolapse, 
maternal pyrexia and instrumentation were responsible for HIE just in 5-15% of cases [7, 8]. 
According to clinical symptoms and laboratory signs, stages of increasing severity can be 
distinguished (see the Sarnat Staging System [9]).  In mild HIE, transient neurological and 
behavioural abnormalities can be observed (eg. increased muscle tone, poor feeding, 
excessive crying or sleepiness).  All symptoms should normalize by the end of the first week 
of life.  Infants with mild asphyxia tend to be free from serious central nervous system 
complications.  In moderately severe HIE, significant lesions can be observed, such as 
seizures in the first 24 hours of life, lethargy, hypotonia and diminished deep tendon reflexes, 
4 
periods of apnea and absent reflexes (grasping, Moro etc.).  Recovery usually takes place in 1-
2 weeks, with a better long-term outcome.  30-50% of these infants have serious long-term 
complications, and 10-20% show minor neurological morbidities.  In severe HIE, generalized 
seizures occur early after the injury, and may be resistant to any conventional therapy.  The 
frequency of seizures may progress during the first 1-2 days.  As the injury progresses the 
electroencephalogram (EEG) becomes isoelectric or shows burst suppression pattern and the 
symptoms of cerebral edema appear.  In addition, other severe neurological signs can appear; 
stupor or coma, lack of neonatal reflexes (eg. swallowing, Moro, sucking, grasping), 
generalized hypotonia and depressed deep tendon reflexes, irregular breathing, fixed or poorly 
reactive pupils, accompanied by the instability of the cerebrovascular circulation and thus 
oxygenation.  In severe birth asphyxia the mortality rate can be as high as 25-50%, but 80% of 
the survivors will develop severe, 20% more moderately severe complications, and as few as 
only 10% will show nearly complete recovery.  The deaths mostly occur in the first week of 
life due to multiple organ failure, or later through severe neurological disabilities due to 
aspiration pneumonia or systemic infections [10].  
Brain hypoxia and ischemia, and the subsequently developing HIE is caused by systemic 
hypoxemia and/or reduced CBF [1-3].  The severity of the final neuronal damage is 
determined by the initial insult aggravated by the effects of reperfusion injury and delayed 
neuronal cell death [2].  It is also observed that the areas primarily affected contain either the 
highest concentration of N-methyl-D-aspartate (NMDA) receptors or where active 
myelination takes place.  In severe forms of asphyxia-induced brain damage, the injury is 
confined mostly to the deep gray matter (eg. putamen, ventrolateral thalamus, hippocampus, 
dorsal brainstem, and lateral geniculate nucleus) and the perirolandic cortex.  Less severe or 
partial insult often results in the so-called watershed injury, injury limited to the intervascular 
boundaries areas [10].  Injuries predominant to the basal ganglia or thalamus are associated 
with unfavourable neurological outcome when compared with infants with white matter 
predominant pattern injury [11].  
The diagnosis of HIE is made based on the history, physical and neurological 
examinations, and laboratory evidence.  The laboratory tests are performed to assess the 
severity of the neuronal injury and to monitor the status of the systemic organs, also to avoid 
hyperoxia and hypoxia as well as hypercapnia and hypocapnia.  The most comprehensive 
status can be obtained by using brain MRI, which is the best imaging modality for the 
diagnosis and follow-up of infants with moderate or severe HIE [12]. 
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Multichannel electroencephalography (EEG) is also an integral part of the evaluation of 
infants diagnosed with HIE.  It can be used to assess the severity of the injury and also to 
evaluate the subclinical electrographic seizures especially for infants on assisted ventilation 
requiring sedation or paralysis [13].  Different EEG characteristics can be associated with 
abnormal outcome (eg. low background amplitude, long interburst interval, electrographic 
seizures, and long term absence of sleep-wake cycling).  Albeit EEG recordings can provide 
good approximation to predict neurological outcome, the evaluation requires a trained 
specialist, and it is often hardly manageable at the bedside. 
The other useful tool in monitoring brain function in moderate-to-severe cases of HIE is 
the single-channel amplitude-integrated electroencephalography (aEEG).  The aEEG is a non-
invasive cerebral function monitor method with the possibility of immediate evaluation that 
can replace the bedside long-term EEG monitoring.  Several studies have shown that aEEG 
performed within a few hours of birth can help in evaluation of severity of HIE [14].  
Although normal aEEG recording may not necessarily mean that the brain is intact, a severe 
or moderately severe aEEG abnormality refers to brain injury and poor outcome.  The 
potential of recovery of the abnormal aEEG within the first 24 hours is usually associated 
with favorable outcome [15]. 
The treatment of HIE in the initial period until recently was largely supportive, limited to 
resuscitation and stabilization.  The following care focused on adequate ventilation and 
perfusion, fluid management, avoidance of hypoglycaemia and hyperthermia.  These 
interventions mainly aimed to avoid further brain injuries but did not offer much hope for 
neuroprotection.   
The gas used for artificial ventilation during resuscitation received a lot of attention in the 
last decade.  Several clinical trials indicate that room air resuscitation for infants with 
perinatal asphyxia is as, or more effective as the resuscitation with 100% oxygen.  In addition, 
room air ventilation provides less oxidative stress by reducing the amount of produced ROS 
[16].  Most infants with severe HIE need ventilation during the first days of life.  The role of 
mechanical ventilation is to maintain the physiological ranges of blood gases and acid-base 
status; to prevent hypoxia, hyperoxia, hypercapnia and hypocapnia.  Animal data suggest that 
hypercapnia may be neuroprotective, however no such evidence is available in newborn.  In 
contrast, hypocapnia may lead to brain hypoperfusion, thus may be associated with worse 
neurodevelopmental outcome [17, 18].  
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Fluid therapy should aim to keep glucose levels stable and ionic homeostasis should be 
maintained in physiological range.  Both hypoglycemia and hyperglycemia may accentuate 
brain damage [19].  
It has been shown that the body temperature critically affects the outcomes in infants with 
moderate-to-severe HIE.  Hyperthermia may be associated with a risk of increase of death or 
severe disability.  For every 1°C increase in the mean of the highest quartile of skin or 
esophageal temperature the risk of death or disability was increased 4-fold [20].  In contrast, 
experimental data have shown that mild hypothermia applied in the initial period of injury (no 
later than 6 hours) is neuroprotective.  The possible neuroprotective mechanisms possibly 
include the reduced metabolic rate, the decreased excitatory transmitter release, reduced 
apoptosis, and reduced vascular permeability preventing edema, and disruptions of other 
blood-brain barrier functions [21, 22].  Recently, the Total Body Hypothermia for Neonatal 
Encephalopathy Trial study group, and some other randomized controlled trials have shown 
that moderate whole-body hypothermia improves outcome in full-term infants by decreasing 
the incidence of severe neurodevelopmental deficits [23-27].  In this group of patients, the 
cooling must begin within 6 hours of injury and maintained for 48-72 hours.  The greater the 
severity of the injury, the longer duration of hypothermia is needed for optimal 
neuroprotection.  It has been proved that applied mild hypothermia caused better outcome two 
years after the hypoxic-ischemic insult [23, 28, 29], likewise better neurodevelopmental 
outcome was shown in school-age patient treated with hypothermia [30].  Thus, body cooling 
recently has become standard care in infants suffered from perinatal asphyxia. 
7 
Animal models in HIE research 
Several research groups are currently investigating other possible neuroprotective 
strategies in order to determine whether these alone or in combination with hypothermia can 
cause favourable outcome after HIE [31-33].  Although these investigations involve a broad 
spectrum of promising avenues, it should be emphasized that a clinical trial in neonates 
requires special attention because of possible implications, ethical issues and financial 
concerns.  For this reason animal models have significant role in seeking suitable therapies 
that can increase survival and attenuate neurological deficits. 
There are numerous reviews providing information regarding the variety, frequency of 
use, and relative appropriateness of both large and small animal models to the study of brain 
injury in the perinatal period [34-38], albeit no model is perfect in reflecting the complexity of 
the human brain and pathology of HIE.  Potential neuroprotective therapies after birth 
asphyxia must be evaluated in newborn animals, because on one hand the younger animals 
have relatively greater resistance to hypoxic-ischemic injury, on the other hand, neurons are 
more vulnerable to injury [39, 40].  Every animal model developed for the study of neonatal 
hypoxic-ischemic injury has to pay attention to the species-specific properties of the chosen 
species. Major attributes having significant impact on the interpretation of results originating 
from an animal model are; 1) how mature is the brain at birth (or at the age of experiment), 
and how does this correlate with a term human infant, 2) what are the species-specific 
characteristics of CBF that would impact on the experimental model, 3) what are the 
important cerebral metabolic considerations, 4) does the model truly mimic the human disease 
or is it more useful in discovering general cellular mechanisms of injury and neuroprotection 
[41].  
By far the most commonly used robust and productive rodent model is the postnatal day 7 
rat developed in 1981 by Vannucci et al. [42] that is used in high number of studies due to the 
availability of large number of animals [36, 37, 43, 44].  The rat model has been well 
characterized over the years, with respect to cerebral metabolic perturbations, neuropathology, 
and attempts at neuroprotection [45, 46].  This model is particularly useful for screening new 
treatment strategies, but it cannot be used in studies where physiologic monitoring is 
important.  Essential differences may exist in the pathomechanisms, shown for example by 
the effect of hyperglycemia during hypoxia-ischemia: neuronal injury is not enhanced by an 
increased blood glucose in rodents, in contrast to the human infants or other large animal 
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models such as newborn pig or adolescent monkey, in which hyperglycemia has detrimental 
effects [47].  
With the increase in availability of transgenic mice, the Vannucci model was adapted also 
to the mouse [48].  Murine models have provided remarkable insights of cellular 
patophysiological mechanisms, due to the short generation times, inexpensive breeding and 
keeping, and the utilization of genetic engineering techniques.  Nevertheless the murine 
models also have numerous disadvantages; there are significant differences in brain size and 
development that aggravate the direct comparison of results between mice and humans [49]. 
One of the effectively used large animal species in HIE studies is the fetal sheep exposed 
to maternal hypoxemia [50, 51]. Studies elucidated the cerebral and systemic metabolic 
effects of acute and chronic cord occlusion and term asphyxia in the sheep fetus [50]. Despite 
the obtained neurophysiological data the model has also major disadvantages; the pregnant 
ewes are large and expensive and the surviving lambs show surprisingly little clinical 
evidence of chronic brain injury.  
Near-term fetal rabbits have also been used to mimic placental insufficiency, persistent 
hypertonia, cerebral palsy and biochemical changes [52-54].  In this model, the preterm rabbit 
fetuses are exposed to sustained placental insufficiency that is monitored with diffusion-
weighted imaging.  These studies can help in the development of therapeutic interventions, 
although, not all the neurological changes are identical to that observed during HIE in human 
infants. 
Presumably the most appropriate large animal model in studying perinatal injuries would 
be a primate model.  The clinical and pathologic changes produced in term monkeys by 
various degrees of asphyxia closely resemble the changes observed in asphyxiated infants [55, 
56].  Further advantages of primate models, that anatomical characteristics and the pace of 
intrauterine development are nearly identical, furthermore the design of management of 
injuries reflects the human neonatal intensive care unit [56].  Thus, the clinical and 
pathological findings are remarkably similar to those that have been noted in human infants, 
rendering this model of potentially highly relevant, particularly for neuroprotective drug trials 
for birth asphyxia before a clinical trial.  Despite of all benefits listed above for primate 
models, the use of nonhuman primates for the study of HIE like for other neurological 
diseases is clearly not applicable at the moment because of the cost in time and resources 
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necessary to develop and use these models combined with ethical considerations and rebuttal 
from animal rights organisations. 
The newborn pig has numerous anatomical and physiological similarities to human infants 
that allow translational conclusions from the experimental findings to clinical settings.  
Similarities in structure and function between pigs and human beings include size, feeding 
patterns, gastrointestinal system, endocrine system, immune system, pulmonary vascular bed 
structure, coronary artery distribution, respiratory rates, tidal volumes, neurological structure 
and social behaviours [57].  In addition, there are genetic similarities, the swine proteins have 
a relatively high sequence homology to humans, 60% compared to the 40% sequence 
homology between rodents and humans.  The pig chromosomal structure has higher similarity 
to humans than those of mouse, rat, dog, cat, horse and cattle [58].  It is especially relevant for 
neonatal research that the physiological properties of newborn piglets, such as birth weight, 
brain developmental stage, and cerebrovascular physiology at birth are very similar to term 
infants.  Due to these similarities, the newborn piglet has been established as a valuable 
experimental tool to study the pathophysiology of neonatal HIE and to test promising new 
therapeutic approaches [59].  In the piglet model, HIE causes damage very similar to the 
pattern of brain injury found in human that have experienced hypoxia-ischemia [60].  
In our laboratory, the newborn piglet model has long been used to study the morphology 
and functional responses of cerebrovascular system in physiologic and pathologic conditions 
[61-67].  We and others have repeatedly shown that hypoxic-ischemic stress in newborn 
piglets severely attenuated CR to various so called “hypoxia-ischemia sensitive” stimuli 
determined in pial arterioles 1 hour after the insult [61, 64, 68-70].  The attenuated CR 
showed spontaneous recovery, and it appeared intact as early as 4 hours after the ischemic 
insult [61, 62, 68, 70].  The impairment of CR is concomitant with neuronal damage, and glial 
activation [71].  
The concept of “neurovascular unit” in neonatal research 
Regulation of CBF is highly dependent on the morphological and functional interaction of 
neurons, astrocytes and various cerebromicrovascular cells [72, 73].  This ‘interaction 
between circulating blood elements and the blood vessel wall, extracellular matrix, glia, and 
neurons’ gave the initial description of neurovascular unit (Report of the Stroke Progress 
Research Group, 2002).  The anatomy and organization of the neurovascular unit incorporates 
the specialized endothelium in cerebral microvessels, sealed by tight junctions and isolated 
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from the surrounding brain cells by basement membrane, the pericytes enveloped in the 
basement membrane, astrocytic endfeet covering more than 98% of the vascular wall, and 
perivascular neurons.  The astrocytes communicate with neurons creating the link for 
endothelial-neuronal coupling, and matching blood flow to metabolic demand by neurons 
[74].  The cellular anatomy of the neurovascular unit has been extended with inflammatory 
cells that interact with the luminal site of brain endothelium, and perivascular macrophages 
and microglia participating in innate immune responses [75].  Besides regulating the local 
blood flow, the neurovascular unit has significant roles in regulation of blood-brain barrier 
permeability and transport, neuroimmune responses, and angiogenesis - neurovascular 
remodelling [76].  Tissue hypoxia is an initial trigger of pathophysiological changes in the 
neurovascular unit.  The hypoxia associated increase in blood-brain barrier permeability, 
water and ion redistribution, and cerebrovascular oxidative stress create secondary injury to 
the neurovascular unit [77, 78].  The contribution of neurovascular unit dysfunction to the 
development of HIE so far has received little attention, although its role in neuronal injury has 
been recently widely recognized in adult stroke [79]. 
The function of the neurovascular unit can be assessed by measuring CR.  During CR 
testing, the system is challenged with a vasoactive stimulus and the response is being 
observed and recorded.  In the literature, CR to three different types of vasodilatory stimuli 
has been most often determined: 1) transient reduction in mean arterial blood pressure [80, 
81], 2) the administration (systemic or local) of a vasoactive chemical substance [82, 83], or 
an 3) an increase in carbon dioxide level [61].  
In our laboratory, for CR determination two stimuli have been selected to test 
neurovascular unit integrity: hypercapnia induced by ventilation with carbon dioxide, and the 
topical application of NMDA.  Hypercapnia causes dose-dependent pial arteriolar dilation in 
newborn pigs that is impaired by moderate-to severe hypoxic-ischemic insult [62, 68, 70, 84].  
NMDA, a synthetic receptor-specific analogue of glutamate, is proved to be vasodilator in the 
cerebral circulation [82].  Similarly to carbon dioxide NMDA causes dose-dependent dilation 
on the pial arterioles and subsequent hyperaemia in piglets that involves the neuronal 
synthesis and vascular actions of NO [65, 85, 86].  
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Neuroprotective treatment perspectives 
As it has already been mentioned, currently only the moderate whole-body hypothermia is 
the only effective treatment of HIE, however, hypothermia alone is unable to provide full 
functional recovery in most patients.  Therefore, further research to find new neuroprotective 
treatments is warranted.  During the management of asphyxiated infants the reoxygenation of 
the tissues is a primary goal of resuscitation efforts; however, reoxygenation and reperfusion 
provide oxygen for the synthesis of ROS that can result in oxidative stress [87-91].  
Moreover, ROS produced in the early reoxygenation period have been shown to be 
responsible for acute neurovascular unit dysfunction [92, 93].  Ventilation with pure oxygen 
has been shown to be detrimental in neonatal large animal models [94-96] and in clinical trials 
as well [92, 93].  Resuscitation is now recommended with air to be supplemented with oxygen 
in infants with persistent central cyanosis [97].  However, the gas mixture used for 
resuscitation could perhaps be used to deliver neuroprotective agents to the brain. 
Molecular hydrogen (H2) has been shown to exert antioxidant properties with selectively 
scavenging the hydroxyl radical, the most aggressive ROS that is produced mostly in 
pathological conditions [98].  In addition to its putatively hydroxyl-radical selective 
antioxidant effect, H2 has other obvious advantages: it can penetrate biomembranes and 
diffuse into the mitochondria and nucleus – the sites of severe cellular oxidative damage.  
Furthermore, inhalation of low concentration of H2 gas has no known side effects.  Due to 
these advantageous features of H2 treatment, the effects of molecular H2 administration has 
been widely tested in ROS-associated neuropathologic conditions in which the outcome can 
be greatly influenced by the rapid bioavailability of the neuroprotective drug in the brain.  H2 
was indeed neuroprotective against hypoxic/ischemic injury in adult and neonatal rats [98-
100] and also in a rat model of Parkinson’s disease [101].  However, the possible protective 
effect of H2 against perinatal asphyxia previously has not been tested in a large animal model.  
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Aims 
In the Cerebrovascular Laboratory at the Department of Physiology, the newborn 
piglet model has been successfully used previously to study acute changes in CR to various 
vasoactive stimuli before and after (up to 4 hours) hypoxic/ischemic stress.  
Therefore, we first wished to investigate in this acute piglet asphyxia model if 1) 
molecular H2 preserves CR to hypoxia/ischemia sensitive vasodilator stimuli and has 
neuroprotective effects.  Additionally, we also assessed if 2) inhalation of H2-supplemented 
room air was safe to newborn pigs in a concentration applied to rodents previously; if 3) H2-
supplemented ventilation per se affected cortical blood flow, the CR or the microscopic 
morphology of the brain in time control animals, and if 4) neuronal cyclooxygenase-2 
expression – a sensitive indicator of neuronal cellular stress was affected by H2 ventilation. 
The positive results and the limitations of these studies urged us to extend our observations to 
the 24h survival time period.  We introduced a new subacute piglet translational HIE model 
that aimed to parallel the early supportive care of HIE patients.  In this new model, we wished 
to investigate if 5) neurovascular unit function was affected 24 hour after asphyxia, if 6) H2 
modified CR to hypoxia/ischemia sensitive stimuli, if 7) H2 affected recovery of brain 
electrical activity after asphyxia, and if 8) H2-induced neuroprotection could be observed by 
histopathology. 
The determination of CR has been traditionally assessed in our laboratory by 
measuring the diameter changes of pial arterioles.  As part of a research collaboration, we 
were involved in the development and in vivo testing of a laser-speckle imager which allowed 
us to assess 9) the effect of pial arteriolar diameter changes on the perfusion changes in the 
cortical parenchyma thus validating our CR determinations on pial arterioles. 
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Materials and methods 
Animals 
Newborn (1-2 days old, body weight: 1,5-2,5 kg) Large-White piglets of either sex (n=81) 
were obtained from a local company (Pigmark Ltd. Co., Szeged, Hungary) on the morning of 
the experiment.  All experiments were approved by the Institution Animal Care and Use 
Committee of the University of Szeged.   
Experimental groups to study the effects of molecular H2 on CR   
The animals were divided into 7 experimental groups (Figure 1.).  The first set of 
experiments (groups 1-4) was designed to investigate the acute neurovascular changes of birth 
asphyxia and 4 hours of reventilation with room air (RA - 21% O2, 79% N2) or H2-
supplemented room air (H2-RA - 2.1% H2; 21% O2; 76.9% N2) depending on the 
experimental group.  The second set of experiments (groups 5-7) was designed to investigate 
the delayed (subacute) neurovascular changes of birth asphyxia and 24 hours of reventilation.  
In groups 5-7 the asphyxia was followed by 4 hours of reventilation with RA or H2-RA 
according to the experimental group, then it was switched to RA in all groups and continued 
for additional 18 hours. 
The experimental groups were the following (Figure 1): 
1) acute time control group ventilated with RA (group 1; n=9);  
2) acute time control group ventilated with H2-RA (group 2; n=7)  
3) acute model of birth asphyxia with RA ventilation (group 3; n=8),  
4) acute model of birth asphyxia with H2-RA ventilation (group 4; n=7),  
5) delayed time control animals ventilated with RA (group 5, n=9),  
6) delayed model of birth asphyxia with RA ventilation (group 6, n=9), and  
7) delayed model of birth asphyxia with H2-RA ventilation (group 7, n=9). 
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Figure 1. Experimental groups and design. 
Animal preparation and birth asphyxia 
Acute model of HIE 
The animals were anesthetized with Na-thiopental (30-40 mg/kg injected ip.) followed 
with an iv. injection of α-chloralose (45 mg/kg).  Supplemental doses of α-chloralose were 
given to maintain a stable level of anesthesia determined by continuous monitoring of arterial 
blood pressure and responsiveness to tactile stimuli.  The piglets were intubated via 
tracheotomy and mechanically ventilated with RA.  The ventilation rate (25-35/min) and the 
peak inspiratory pressure (100-125 mmH2O) were adjusted to maintain the arterial blood gas 
values and pH in the physiological range.  The right femoral artery and vein were catetherized 
to monitor arterial blood pressure, blood gases and pH, and to administer drugs and fluids, 
respectively.  Body temperature was maintained within a physiological range (38-39˚C) by an 
electric heating pad.  
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After obtaining baseline CR values, asphyxia was induced (group 3 and 4) by suspending 
the artificial ventilation and clamping the endotracheal tube for 10 min (Figure 1).  
Reventilation started with the gas mixtures according to the protocol of the respective 
experimental groups.  In the time control groups, ventilation was switched to the respective 
gas mixtures after a RA ventilation time control period (10 min).  Following 1 hour 
ventilation, CR to hypercapnia and NMDA were repeatedly determined in all experimental 
groups, continued by ventilation for additional 3 hours.  At the end of the 4-hours survival 
period, the anesthetized piglets were euthanized with KCl (2 M, 10 mL iv.). 
Delayed model of HIE 
Anesthesia was induced with ip. injection of Na-thiopental (45 mg/kg) followed by 
intubation through tracheotomy and artificial ventilation with RA, using a pressure-controlled 
ventilator.  The ventilation rate (25-35/min) and the peak inspiratory pressure (100-125 
mmH2O) were set to keep blood gases and oxygen saturation in the physiological range.  The 
right femoral and jugular veins were catheterized to monitor pH, pCO2, glucose, and to inject 
drugs and fluids, respectively.  Anesthesia/analgesia was continued with iv. injection of 
loading dose of morphine (100µg/kg), and midazolam (250µg/kg), and was then maintained 
with intravenous infusion of morphine (10 µg/kg/h), and midazolam (250 µg/kg/h) along with 
fluids (5% glucose, 0.45% NaCl, 2-5 ml/kg/h), with additional boluses if necessary.  Every 12 
hours intravenous antibiotics were given (penicillin 50 mg/kg; gentamycin 2,5 mg /kg).  
After the initial preparation, the animals were placed in a prone position into an ICU 
newborn resuscitation crib (SPC 78-1, Narco Air-Shields Inc., Hatboro, Pennsylvania, USA).  
Core body temperature was maintained within a physiological range (38,5 ±0,5˚C) with a 
servo-controlled overhead radiant heater.  Additional heating was provided with an electric 
heating pad if necessary.  Oxygen saturation, heart rate, ECG, arterial blood pressure, and 
body temperature were non-invasively monitored with a Hewlett Packard M1094 monitor 
(Palo Alto, California, USA); the data were on-line recorded using a PC (MecifView, 
Arlington, MA, USA).  The aEEG was performed with two biparietal needle electrodes 
coupled to an EEG amplifier (Experimetria Ltd., Balatonfüred, Hungary), the raw EEG data 
were converted to aEEG recording and stored on a PC using a custom software designed 
according to the specifications described previously [102].  
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Score Description Minimum Maximum 
0 Isoelectric 0 < 2µV
1 Low voltage 0 < 5µV
2 Burst suppression <5µV < 10µV
3 Discontinuous 1 < 5µV 10-25µV 
4 Discontinuous 2 < 5µV < 25µV
5 Continuous > 5µV < 25µV  
Table 1. aEEG evaluation scoring system. 
In group 6 and 7, asphyxia was induced by suspending the ventilation for 8 minutes 
and continued with reventilation with the gas mixture according to the experimental group 
(Figure 1).  Four hours following asphyxia the ventilation was continued with RA in every 
group.  In the entire reventilation period, FiO2 was increased in some animals from 21% up to 
25% to maintain satisfactory oxygenation.  Vital parameters and aEEG were continuously 
monitored, and recorded for 10 min before the asphyxiation, during the asphyxia, for the first 
10 minutes of reventilation and then 10-10 min from the 1st to the 22
nd
 hours of reventilation 
each hour.  The aEEG background pattern was evaluated with a scoring system (Table 1) 
based on [14].  Venous pH, blood gases, and blood glucose level were checked every 4 hours. 
CR was determined sequentially to graded hypercapnia, NMDA (10 and 100μM), NA (10 
and 100μM), and SNP (1 and 10μM) 24 hours after the asphyxia.  After examination of CR 
the common carotid arteries were bilaterally cannulated in the deeply anesthetized animals 
and the brain was perfused with cold (4˚C) saline. 
Closed cranial window/intravital videomicroscopy and determination of CR 
To determine CR the anesthetized animals were equipped with a closed cranial window 
[103].  The head of the piglet was fixed in a stereotaxic frame.  The scalp was incised and 
removed together with the connective tissue over the calvaria.  A circular craniotomy was 
made in the left parietal bone.  The dura was cut and reflected over the skull.  A stainless steel 
cranial window with three injectable ports was placed into the craniotomy, sealed with bone 
wax and cemented with dental acrylic.  The window was filled with artificial CSF (aCSF) 
warmed to 37˚C.  The pial vessels (~100µm in diameter) were visualized with by using an 
operating microscope (Wild, Switzerland) equipped with a CCD camera (A.Krüss, Germany) 
connected to a video monitor.  Vascular diameters were measured using video microscaler.  
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After the visualized arteriole stabilized its baseline diameter, the window was flushed with 
aCSF.  Vasodilator stimuli were: 1) graded hypercapnia (ventilation with gas mixture of 5 or 
10% CO2, 21% O2, balance N2), 2) local application of NMDA (10-100µM), 3) NA (10-
100μM), and 4) SNP (1-10μM).  All drugs were dissolved in aCSF.  The effects of 
hypercapnia and NMDA were tested for 5 minutes, of NA and SNP for 3 minutes.  During 
each stimulus arteriolar diameters were observed continuously.  After each stimulus the 
cranial window was repeatedly flushed with aCSF and the vessel diameter was allowed to 
return to baseline level. 
Drugs 
Sources: Na-thiopental (Sandoz, Kundl, Austria); morphine hydrochloride, penicillin 
(Teva, Petah Tikva, Israel); midazolam (Torrex Pharma, Vienna, Austria); gentamycin, NA 
(NA; Sanofi, Paris, France); α-chloralose, N-methyl-D-aspartate (NMDA), sodium 
nitroprusside (SNP; Sigma Aldrich, St. Louis, MO, USA).  All gas mixtures used for 
ventilation were obtained from the Messer Group Gmbh, Bad Soden, Germany. 
Neuropathology 
Additional group of piglets (NAIVE, n=3) were euthanized with Na-thiopental (150 
mg/kg i.p.) to provide an absolute control for the neuropathology studies.  After euthanasia in 
all experimental groups, the brains were rapidly and carefully removed and immersion fixed 
in 4% paraformaldehyde within 5-6 min.  Tissue blocks from the frontal, parietal, temporal, 
and occipital cortices, the hippocampus, the cerebellum, the basal ganglia, the pons, and the 
medulla oblongata were embedded in paraffin, and sections were double stained with 
hematoxylin and eosin (H/E).  Neuronal damage was evaluated on H/E stained sections via 
determining the percentage of damaged, shrunken hyperchromatic (red) neurons with 
pyknotic nuclei compared with the total number of neurons by an examiner blinded to the 
experimental groups. 
COX-2 immunohistochemistry 
For COX-2 immunohistochemistry, brain samples from the frontal, parietal, temporal and 
occipital lobes of the cerebral cortex, the hippocampus, the caudate nucleus, the cerebellum, 
the pons, and the medulla oblongata of the animals of group 1, 2, 3 and 4 were dissected.  The 
samples were dehydrated, paraffin embedded, and 4 μm thin coronal sections were cut from 
the paraffin blocks.  The sections were mounted on sylanized slides, were incubated at 56°C 
18 
overnight, then dewaxed in xylene and rehydrated in descending alcohol gradient.  Slides 
were incubated in 3% H2O2 in methanol to block endogenous tissue peroxidase activity.  
Antigen retrieval was performed by boiling the slides for 3 min using citrate buffer (pH=6.0) 
solution.  After cooling at room temperature, slides were incubated with a 1:200 dilution 
rabbit monoclonal primary antibody against COX-2 (clone SP21, Labvision, Fremont, 
California, USA) for 30min.  The secondary anti-rabbit antibody was conjugated with high 
affinity horseradish peroxidase-polymer system (EnVision; Dako, Glostrup, Denmark).  For 
visualization, 3,3'-diaminobenzidine (DAB) tetrahydrochloride solution was used.  Slides 
were counterstained with hematoxylin then dehydrated in increasing concentrations of 
alcohol, cleared in xylene and coverslipped.   
COX-2 immunoreactive neurons were manually counted by two independent observers 
blinded to the experimental group.  In each examined brain region, the percentage of stained 
neurons was determined by dividing the number of immunopositive neurons by the total 
number of neurons observed in 5 randomly selected fields of view at 20× magnification using 
light microscopy.  In addition, reflecting staining intensity the immunoreactive neurons were 
ranked: 1+, 2+, or 3+ scores were given corresponding with weak, perinuclear staining (1+), 
moderate cytoplasmic staining (2+) and strong cytoplasmic and dendritic staining (3+) 
respectively.  
MAP-2 immunohistochemistry 
For MAP-2 immunohistochemistry brain samples from group 5, 6 and 7 were used.  
Paraffin embedded sections (4 μm) were mounted on sylanized slides, incubated at 56°C 
overnight, then dewaxed in xylene and rehydrated in descending alcohol gradient.  The slides 
were incubated with a 1:200 dilution rabbit monoclonal anti-MAP-2 (ExBio, Czech Republic) 
for 30 min using an automatic slide stainer.  The secondary anti-rabbit antibody was 
conjugated with high affinity horseradish peroxidase-polymer system (EnVision®; Dako, 
Glostrup, Denmark).  For visualization, DAB tetrahydrochloride solution was used.  Slides 
were counterstained with hematoxylin then dehydrated in increasing concentrations of 
alcohol, cleared in xylene and coverslipped.  
Evaluation of immunohistochemistry slides were performed according previously 
described methods [104]; briefly, images of whole labelled sections were scanned with 
automatic digital slide scanner (Panoramic MIDI, 3DHistech, Budapest, Hungary) and 
imported into Image Pro Plus 6.0 (Media Cybernetics, Bethesda, USA).  Images were then 
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converted to greyscale and thresholded at the same level in each image to produce images 
consisting only of black (labelled) or white (unlabelled) pixels.  The percentage of the labelled 
(black) area was determined and designated as the MAP-2 score of the respective area. 
Laser speckle contrast analysis (LASCA) technique 
An additional group of piglets (group 8; n=20) were instrumented for Laser-speckle 
imaging.  The methodology of anesthesia and implantation of the closed cranial was the same 
as described for the acute asphyxia model.  However, the cranial window was illuminated in 
this case by the polarized light of a near infrared ( =808 nm) diode laser.  Speckle images 
were recorded by a monochrome camera (Pixelink PL-B771F, resolution: 1280×1024 pixels).  
Laser speckle images were stored on a personal computer and LASCA was performed offline 
according to a previously described method [105].  The relative changes in pial arteriolar 
diameters were also determined on the speckle contrast images.  
The window was flushed gently with aCSF, and baseline perfusion images were obtained 
after a stabilisation period.  Then the following vasoactive stimuli were applied: H2-
supplemented room air (2.1% H2, 21%O2, balance N2), graded hypercapnia (ventilation with 
gas mixture of 5 or 10% CO2, 21% O2, balance N2), local application of NMDA (100µM), 
NA (10-100µM), and asphyxia-reventilation.  The effects of hypercapnia, H2-RA and NMDA 
were tested for 5 minutes, NA for 3 minutes.  During each stimulus speckle image series were 
taken continuously with 1 frame/s frequency.  
Statistical analysis 
Parametric data are expressed as mean±SEM.  Data were analyzed with a statistical 
software (SigmaPlot 11, Systat Software Inc., San Jose, CA, USA).  CR and physiological 
parameters were analyzed with two-way repeated measures ANOVA, the morphometric data 
and LASCA with one-way ANOVA.  For pairwise comparisons the Student-Newman-Keuls 
post hoc test was used.  In case histopathology data were not normally distributed were 
analyzed with Kruskal-Wallis ANOVA on Ranks followed by the Dunn’s post hoc test for 
multiple comparisons.  The aEEG scores of Group 6 and 7 were compared with the Mann-
Whitney U-test. P values <0.05 were considered statistically significant. 
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Results 
  The baseline values of all monitored vital parameters, such as mean arterial blood 
pressure, heart rate, pH, blood gases, and body core temperature were in the physiologic range 
and did not differ significantly between the experimental groups.  
Acute effects of asphyxia on vital parameters and CR  
Asphyxia caused decrease in the MABP and CoBF that were similar in groups 
subjected to asphyxia (group 3 and 4).  At the onset of reventilation, MABP stabilized at near 
baseline values by the end of first hour (Table 2).  MABP values were thus similar when 
determining CR to hypercapnia and NMDA before and after A/R.  
Baseline Asphyxia 10 min 1 h 2 h 3 h 4 h
Group 1 MABP 78±3 N/A N/A 69±4 65±3 62±4 63±4
CoBF 100±0 N/A N/A 119±19 121±22 108±15 117±21
Group 2 MABP 70±7 N/A N/A 63±4 57±7 59±7 63±8
CoBF 100±0 N/A N/A 93±5 80±8 80±8 85±11
Group 3 MABP 77±4 47±8 70±3 66±6 60±4 58±4 65±4
CoBF 100±0 31±7 83±4 107±5 101±9 103±5 105±7
Group 4 MABP 74±5 41±12 70±3 51±3 63±5 55±4 57±4
CoBF 100±0 29±5 96±5 69±3* 81±6 76±8* 79±10*
Reventilation
Table 2. MABP (mmHg) and CoBF (PU) data 
In the normoxic time control groups, the MABP remained in the normal range during 
the whole course of the experiment.  CoBF seemed to slightly decrease by 15–20% in group 2 
compared with group 1; however, this tendency did not reach statistical significance.  In 
contrast, CoBF was moderately lower (20-25%) in the group 4 compared with the group 3 
(Table 2).  
Asphyxia caused significant hypoxia, hypercapnia, acidosis in both groups subjected 
to birth asphyxia.  Notably however, both at 30 min and at 1 h after asphyxia, pCO2 was 
significantly higher in group 3 compared with group 4, albeit pH and pO2 values were not 
significantly different (Table 3).  
 
21 
Baseline 5%CO2 10%CO2 Asphyxia 10 min 30 min 1 h 5%CO2 10%CO2
Group 1 pH 7.53±0.02 7.32±0.03 7.15±0.02 N/A 7.45±0.06 7.46±0.05 7.44±0.06 7.30±0.03 7.16±0.04
PCO2 (mmHg) 26±2 44±3 65±10 N/A 29±6 32±7 35±6 51±5 71±8
PO2 (mmHg) 89±8 89±7 93±5 N/A 92±9 92±9 84±9 85±7 93±5
Group 2 pH 7.53±0.06 7.30±0.02 7.15±0.02 N/A 7.46±0.04 7.44±0.05 7.42±0.05 7.26±0.04 7.09±0.03
PCO2 (mmHg) 33±2 51±5 85±6 N/A 34±3 35±4 37±6 57±3 85±5
PO2 (mmHg) 78±3 75±4 66±7 N/A 74±7 75±9 70±7 77±6 70±12
Group 3 pH 7.3±0.10 7.06±0.13 7.09±0.04 6.76±0.03 7.06±0.07 7.14±0.09 7.20±0.09 7.05±0.09 7.04±0.04
PCO2 (mmHg) 29±1 51±6 80±5 133±10 59±8 43±5 56±9 71±12 90±11
PO2 (mmHg) 82±4 86±4 85±5 11±1 66±8 61±5 60±8 70±9 70±13
Group 4 pH 7.28±0.09 7.20±0.07 7.05±0.05 6.85±0.07 7.12±0.07 7.21±0.08 7.24±0.09 7.10±0.08 7.01±0.06
PCO2 (mmHg) 31±4 48±5 77±5 123±12 44±5 32±4* 31±3* 54±5 82±3
PO2 (mmHg) 71±4 81±4 86±3 5±0.4 69±6 66±4 68±4 78±5 77±3
Hypercapnia before 
asphyxia Reventilation
Hypercapnia after 
asphyxia
Table 3. Blood chemistry data in the acute period following asphyxia 
Ventilation with gas mixtures containing 5% or 10% CO2 to determine CR to graded 
hypercapnia resulted in graded increase in arterial pCO2 with simultaneous drops in pH in all 
groups before and after asphyxic event (Table 3). 
Graded hypercapnia elicited significant, dose-dependent, pial arteriolar vasodilation in 
all experimental groups (Figure 2A).  Baseline pial arteriolar diameters were not significantly 
different between repeated hypercapnia stimulations (first versus second stimulation: 85±4μm 
vs. 91±3μm for group 1, and 86±6μm vs. 82±7μm for group 2, 88±4μm vs. 94±8μm for group 
3, 87±4μm vs. 92±7μm for group 4).  A/R significantly reduced CR to hypercapnia in group 3 
(Figure 2A) but not in the other experimental groups (Figure 2A).  Thus, ventilation with H2-
RA under normoxic conditions in group 2 did not affect CR to hypercapnia.  Furthermore, 
ventilation with H2-RA after asphyxia prevented the reduction of CR to hypercapnia in the 
group 4 (Figure 2A).  
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NMDA induced significant, repeatable pial arteriolar vasodilation before and after 
A/R in all experimental groups (Figure 2B).  Baseline pial arteriolar diameters did not differ 
significantly between repeated NMDA applications (first versus second application: 86±4μm 
vs. 82±4μm for group 1, and 84±5μm vs. 80±6μm for group 2, 87±4μm vs. 85±9μm for group 
3, 85±4μm vs. 91±6μm for group 4).  
Neuropathology – acute neuronal changes 
The percentage of damaged neurons was negligible in any brain region of the 
untreated control animals (NAIVE animals): the median value was 0% in seven regions 
(temporal and occipital cortices, CA1, CA2, CA3 and granular region of the hypocampus and 
cerebellum), 2% in three regions (frontal cortex, caudate nucleus and medulla), and 3% in two 
regions (parietal cortex and pons).  
In the time control animals (group 1 and 2), there was also only a 1–4% neuronal 
damage depending on the brain region studied, indicating that H2-RA ventilation alone did not 
affect neuronal viability (Figs. 3 and 4A–C).  A/R significantly increased neuronal injury in 
all brain regions studied in the group 3.  However, the increase in injured, red neurons was 
Figure 2.  Ventilation with H2-
supplemented room air preserves 
CR to hypercapnia 1 hour after 
asphyxia. Both stimuli (hypercapnia 
and topical application of NMDA) 
elicited similar, significant 
increases in pial arteriolar diameters 
in all experimental groups.  In time 
control groups, responses were 
repeatable and similar between 
group 1 and 2.  After asphyxia pial 
arteriolar dilation to 10% CO2 was 
significantly reduced in group 3, 
however in group 4 it was not 
significantly different from the 
respective baseline response before 
asphyxia. p<0,05 * versus 
corresponding response before 
asphyxia, † versus corresponding 
response after asphyxia in group 3. 
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smaller in group 4, showing neuroprotective effect in virtually all examined brain regions 
(Figs. 3 and 4A–C). 
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Figure 3. Representative photomicrographs from the parietal cortex, the stratum granulare of 
the hippocampus, and the cerebellar cortex showing neuroprotection by H2-RA ventilation in 
the early survival period (4 h reventilation).  Shrunken, hyperchromatic (red) neurons with 
pyknotic nuclei are more common in samples obtained from animals of the group 3 as 
compared with group 4.  Time control groups (group 1 and 2) show minimal neuronal 
damage, the samples are similar to those obtained from untreated (NAIVE) animals. Scale 
bar: 100µm. 
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Figure 4. Neuronal injury 
was quantitatively 
determined by cell counting 
at 4h survival after asphyxia 
and in corresponding time 
control animals.  The 
examined brain regions 
were Panel A: CA1, CA2, 
CA3, and stratum 
granulosum of the 
hippocampus; Panel B: 
frontal, parietal, temporal 
and occipital cortices; and 
Panel C: basal ganglia, 
pons, medulla, and 
cerebellum. Pooled data 
from the hippocampal and 
cortical subregions are also 
shown on Panels A and B, 
respectively. The box plots 
show the median 
(horizontal line), the 25th-
75th percentile (box), the 
10th-90th percentile (error 
bars), and any outlying data 
points (bullets). The 
experimental groups are 
represented by white, light 
gray, gray and dark gray 
boxes for groups 1, 2, 3, 
and 4, respectively. A/R 
resulted in significant 
increases in neuronal injury 
in virtually all examined 
brain regions in group 3 but 
not in group 4 compared 
with the respective time 
controls. P<0.05, * versus 
corresponding time control, 
† group 3 versus group 4. 
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Regional COX-2 expression  
 
We determined the ratio of COX-2 immunopositive neurons in various brain regions 
in the 4 acute groups of piglets (group 1-4) undergoing the A/R and/or the neuroprotective 
hydrogen ventilation treatment (Table 4). 
Frontal Parietal Temporal Occipital CA1 CA2 CA3
Granular 
layer
1+ 28±6 34±4 17±3 16±3
2+ 16±3 21±3 8±1 7±1
3+ 5±1 7±1 7±3 4±1
Σ 48±7 62±6 31±4 27±4
1+ 34±4 34±5 21±2 15±3
2+ 16±3 19±4 13±2 9±2
3+ 10±4 9±2 7±2 5±1
Σ 60±5 63±8 40±2 29±4
1+ 27±8 28±4 26±6 17±4
2+ 25±7 26±4 14±1 12±3
3+ 13±5 12±3 8±2 7±2
Σ 65±12 66±6 48±9 36±8
1+ 33±5 32±8 25±3 18±4
2+ 23±2 37±4 16±3 12±3
3+ 10±2 13±3 9±4 6±1
Σ 66±5 81±5 49±4 36±7
12±2 3±0 1±0 2±1
Group 1 (n=8)
Group 2 (n=7)
Group 3 (n=6)
Group 4 (n=5)
Cortex Hippocampus
14±3 4±1 3±1 3±1
24±7 8±5 2±1 5±3
10±3 3±1 2±1 2±1
 
Table 4. The percentage of COX-2 immunopositive neurons in the piglet cerebral cortex and 
hippocampus 
COX-2 immunopositivity was observed in neurons and in microvessels.  We observed 
COX-2 immunopositive neurons cortical samples from all cerebral lobes, in all cortical layers 
(Figure 5A-D).  Marked neuronal COX-2 positivity was found in two distinct layers of the 
cerebral cortex: in the oval-shaped cells in cortical layer III and pyramidal cells in layer V.  
There was no statistically significant difference among the 4 experimental groups (group 1, 2, 
3 and 4) either in the ratio of immunopositive neurons or their staining intensity (Table 4).  In 
contrast, we observed striking regional differences in the ratio of COX-2 immunopositive 
neurons among the four cerebral lobes.  To assess this interesting observation, data from 
normoxic and asphyxiated animals were pooled to better detect the regional differences.  
COX-2 immunoreactive neurons were almost twice as numerous in the frontal and the parietal 
cortices, than in the temporal and the occipital lobes (Figures 5A-D and 6A).  Interestingly, 
this regional difference was not reflected in the staining intensity of the immunopositive 
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neurons; instead, the proportions of 1+, 2+, 3+ neurons were remarkably similar in all 4 
regions: ~ 50%, 35%, 15%, respectively (Figure 6C).  
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Figure 5. Representative photomicrographs showing COX-2 immunostaining in different 
regions of the of newborn pig brain.  In the frontal (A) and the parietal cortex (B) strong 
cytoplasmic and dendritic expression can be observed in large percentage of the neurons, 
unlike in the temporal (C) and occipital cortex (D).  All subregions of the hippocampus, such 
as the granular layer (E), the CA1 (F), the CA2 (G), and the CA3 (H) show generally weak 
neuronal staining.  Scale bar represents 100µm. 
In the hippocampus, COX-2 immunostaining was considerably less pronounced than 
in the cortex with only few immunopositive neurons (Figure 5E-H).  There was also no 
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significant difference among the 4 experimental groups (Table 4).  The highest expression 
was found in the pyramidal cells of the CA1 field, while there was minimal immunopositivity 
in the CA2, CA3 regions and the granular layer of the hippocampus (Figure 6B).  The staining 
intensity could not be reliably evaluated due to the scarcity of immunopositive neurons. 
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Figure 6. Regional neuronal COX-2 expression and staining intensity in the piglet cortex.  
The examined brain regions were: Panel A: Frontal, Parietal, Temporal and Occipital cortices, 
Panel B: CA1 (HP-CA1), CA2 (HP-CA2), CA3 (HP-CA3), Stratum granulosum (HP-Gr) 
hippocampal subregions.  On Panels A and B the percentage of COX-2 positive neurons 
compared to the total number of neurons were plotted on the bar graphs (mean±SEM), while 
on Panel C the staining intensity grades were plotted in percentage of total number of labelled 
neurons.  In the neocortex, the temporal and occipital cortices show significantly lower basal 
COX-2 expression than the frontal and the parietal regions (Panel A, *p<0.05, versus the 
frontal and the parietal cortices).  However, the staining intensity grades of COX-2 
immunopositivity showed a very similar pattern in all neocortical areas (Panel C).  In the 
hippocampus, all subregions displayed low percentage of COX-2 immunopositive neurons 
(Panel B). 
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In the assessed subcortical regions, there was no remarkable COX-2 immunostaining.  
The numbers of stained neurons were less than 1% showing patchy staining of neurons in the 
pons, medulla, cerebellum, and the caudate nucleus.  In the cerebellum, COX-2 
immunopositivity was observed in a small fraction of the Purkinje cells.  Similar to the 
cortical regions, asphyxia or H2-RA ventilation did not cause significant alteration in the 
minimal COX-2 immunostaining. 
 
Delayed changes in vital parameters and CR following birth asphyxia 
In the time control group, the monitored physiological parameters (heart rate, blood 
pressure, blood gases and pH, core body temperature and O2 saturation) were stable and 
within the physiological range (Figure 7).  The aEEG showed continuous activity (score 5) 
throughout the whole observation period.  In groups exposed to asphyxia, it caused isoelectric 
aEEG within 1-2 minutes (score 0), and severe hypoxia, hypercapnia, hypotension and 
bradycardia developed by the end of the asphyxic period.  During reventilation these 
physiological parameters gradually recovered in 2-3 hours and then they did not differ from 
the time controls (Figure 7).  The isoelectric aEEG recovered with large interindividual 
variability by the 22 hours observation period, although there was marked tendency of faster 
recovery in the H2-RA ventilated group that was statistically significant in the first 4 hours of 
reventilation (Figure 8). 
29 
40
39
38
37
36
T
e
m
p
e
ra
tu
re
 (
 C
)
1 22
300
250
200
150
100
H
ea
rt
 r
a
te
 (
b
p
m
)
Survival time (h)
1 22
100
90
80
70
60
50
S
y
st
o
li
c 
p
re
ss
ir
e
(m
m
H
g
)
1 22
100
80
60
40
20
0
S
p
O
2
 (
%
)
1 22
Group 5
Group 6
Group 7
 
Figure 7. Rectal temperature and hemodynamic parameters in the experimental groups 5-7 
over the course of 22 hours after asphyxia.  Body temperature was tightly regulated and did 
not significantly differ among the experimental groups.  The oxygen saturation was gradually 
restored within 3 hours after asphyxia and later did not differ significantly from the values 
obtained in time controls.  Systolic blood pressure was also in the physiological range and 
was not different among groups.  Asphyxia resulted in tachycardia during the early 
reventilation period that was later restored, however the animals exposed to asphyxia showed 
a tendency for elevated heart rate throughout the observation period.  
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Figure 8. aEEG scores in groups 6 and 7 
over the course of 20 hours after asphyxia. 
aEEG scores were determined each hour of 
survival were summated over 4-hour 
periods.  The aEEG score in every animal 
of the time control group (group 5) was 5 
throughout the observation period (not 
illustrated).  Dark gray boxes are 
representing group 6, light gray boxes 
group 7.  The presented box plots show the 
median value (thick line), the 25-75
th
 
percentile (box), and the 10-90
th
 percentile 
(error bars). * p<0,05 versus asphyxia.  
pH pCO2 glucose pH pCO2 glucose pH pCO2 glucose 
Baseline 7,4±0,2 36±10 3,5±1,6 7,4±0,1 39±6 5,6±2,8 7,4±0,1 36±9 5,9±5,0
Asphyxia 6,9±0,1* 89±34* 7,0±0,1* 94±14*
4h 7,4±0,1 43±10 4,0±2,1 7,4±0,1 45±10 4,3±1,4 7,4±0,1 42±16 3,7±1,5
8h 7,3±0,1 47±18 3,3±1,7 7,3±0,1 43±10 4,5±2,8 7,3±0,1 48±10 4,5±3,2
12h 7,3±0,1 49±18 4,3±3,0 7,3±0,1 45±14 4,0±1,5 7,3±0,1 45±14 3,9±2,5
16h 7,3±0,2 48±17 3,2±1,3 7,3±0,1 49±16 4,9±2,8 7,4±0,1 50±10 3,1±1,0
20h 7,4±0,1 38±12 4,3±2,0 7,3±0,1 47±17 2,8±0,4 7,3±0,1 53±19 3,1±0,5
Group 5 (n=9) Group 6 (n=9) Group 7 (n=9)
 
Table 5. Venous blood pH, pCO2 (mmHg) and glucose levels (mM) during the observation 
period. * p<0,05 versus respective baselines. 
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Graded hypercapnia resulted in similar increase in arterial pCO2 together with 
decrease in pH in all experimental groups (Table 5).  5-10% CO2 ventilation caused dose-
dependent pial arteriolar dilation in Group 5 (Figure 9A).  In contrast, CR to graded 
hypercapnia was severely impaired 24 after asphyxia in group 6, but intrinsically unaffected 
in the animals ventilated with H2-RA (group 7; Figure 9A). 
pH pCO2 pO2 pH pCO2 pO2 pH pCO2 pO2
Group 5 7.43±0.03 35±4 91±5 7.32±0.02 43±3 96±4 7.19±0.02 60±3 99±8
Group 6 7.42±0.03 36±4 77±5 7.30±0.01 41±4 85±9 7.17±0.02 64±3 87±7
Group 7 7.38±0.04 40±4 79±4 7.30±0.03 48±4 83±5 7.19±0.02 69±2 89±6
Baseline 5% CO2 10% CO2
Table 5. Arterial blood pH, pCO2 (mmHg), and pO2 (mmHg) values during graded 
hypercapnia 
NMDA caused graded vasodilation in group 5, but it was abolished in group 6, and 
severely attenuated in group 7, however CR to NMDA was significantly higher in H2-RA 
ventilated group (group 7) compared to RA group (group 6; Figure 9B). 
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The arteriolar constriction to NA or dilation to SNP was not significantly affected by 
asphyxia, although it is 
remarkable that NA caused 
significantly smaller 
vasoconstriction in group 7 
compared to time control 
animals (group 5; Figures 9C 
and D). 
Figure 9. CR determined to 
various stimuli 24 hours after 
asphyxia.  Baseline pial 
arteriolar diameters were not 
significantly different among 
the experimental groups.  
Panel A: Graded hypercapnia 
elicited concentration-
dependent vasodilation that 
vas severely attenuated in the 
asphyxiated animals.  Panel 
B: NMDA elicited dose-
dependent vasodilation that 
was abolished after asphyxia. 
NMDA-induced vasodilation 
was also significantly 
attenuated in the H2-
ventilated group, however, 
the response was significantly 
larger compared to the RA-
ventilated group.  Panel C: 
NA elicited pial arteriolar 
constriction that was 
significantly altered by 
asphyxia.  NA-induced 
vasoconstriction was 
significantly smaller in the 
H2-ventilated group.  Panel D: 
SNP could dilate pial 
arterioles in all three 
experimental groups, 
although there was a tendency 
for smaller responses in the 
animals subjected to 
asphyxia. p<0,05 * versus 
group 5, † versus group 6. 
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Delayed neuronal injury at 24h survival  
In group 5, there was only a mild perivascular edema with no gross histological 
alteration discernible in any brain regions studied.  Accordingly, the neuronal injury was 
minimal in all regions (Figure 10).  In group 6, asphyxia elicited only small, nevertheless 
statistically significant increases in the percentage of irreversibly damaged neurons in most 
neocortical areas, the CA1 region of the hippocampus, the cerebellum, and the medulla 
oblongata (Figures 10).  H2-RA in group 7 resulted in a modest neuroprotective effect: 
neuronal damage was significantly smaller in the frontal cortex (vs. group 6), and there was 
no significant difference between group 5 and 7 in the CA1 region, the cerebellum, and the 
medulla oblongata (Figure 10). 
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Figure 10. Neuropathological evaluation of different brain regions in the experimental groups 
5, 6 and 7 24 hours after asphyxia.  In time controls damaged neurons were rare.  Asphyxia 
elicited a modest but statistically significant increase in the frequency of damaged red neurons 
in most areas of the cerebral cortex, the CA1 region of the hippocampus, the cerebellum, and 
the medulla oblongata.  There was no significantly elevated neuronal damage in the caudate 
nucleus, the occipital cortex, and other assessed hippocampal areas (data are not plotted).  In 
most regions H2 ventilation had a small neuroprotective effect. p<0,05 * versus time controls 
(group 5), † versus asphyxia (group 6).  
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Figure 11. Representative photomicrographs of frontal cortex, CA1 region of hippocampus 
and medulla oblongata shoving neuronal damage after 24 hours of survival.  Magnification 
20X, scale bar: 100 µm. 
MAP-2 density 
MAP-2 immunoreactivity was present in the cortex, hippocampus, basal ganglia, 
thalamus and brainstem, both in perikarya and the dendrites. 
Asphyxia did not result in significant change in MAP-2 immunoreactivity in any 
tested brain region 24 hours 
following asphyxia (Figure 12.).  
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Figure 12. MAP-2 density after 24 hours of 
survival.  In the assessed regions there was no 
difference in relative density among 
experimental groups. 
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Figure 13. Representative photomicrographs of the MAP-2 immunohistochemistry in the 
frontal cortex 24 hours following asphyxia (left panels) and the same regions after conversion 
into the black/white images thresholded at the same level (right panels). Magnification 20X, 
scale bar represents 100 µm. 
 
LSI/LASCA studies on the cortical microcirculation 
In group 8, the cortical microcirculation and CR were assessed with LASCA.  Laser-
speckle contrast images (LSI) analyzed with LASCA showed unchanged parenchymal 
perfusion, pial arteriolar diameters and flow velocity during H2-RA ventilation.  Ventilation 
with 5% and 10% CO2 elicited graded hypercapnia and acidosis similar to those levels 
obtained in the previous studies: arteriolar pCO2 increased from 28±3 mmHg to 47±5* and 
65±7**, arterial pH decreased from 7.41±0.03 to 7.34±0.03* and 7.24±0.05** respectively; 
p<0.05, * versus baseline, ** versus baseline and smaller hypercapnia grade).  Graded 
hypercapnia elicited dose-dependent pial arteriolar vasodilation (Figure 14A), and LASCA 
could show the increased velocity of blood flow in dilated arterioles (Figure 14B).  
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Application of NMDA induced a marked increase in pial arteriolar diameters, but no change 
in arteriolar flow velocity compared to baseline level.  However, parenchymal perfusion 
significantly increased in response to both hypercapnia and NMDA, in accordance with the 
calculated increases in arteriolar flow (Figure 14C and D).  Both doses of NA resulted in 
significant constriction of pial arterioles similarly to the velocity of blood flow in the 
constricted arterioles indicating a greatly reduced pial arteriolar flow.  Although NA also 
significantly reduced parenchymal flow velocities reflecting decreased cortical blood flow, 
this change appears to be only ~55-60% of the reflective change in the pial arteriolar flow.  
Asphyxia resulted in severe hypotension, hypoxia, hypercapnia and acidosis; MABP 
decreased from 70±5 to <40mmHg, pO2 values decreased from 89±14 to 8±2*mmHg, pCO2 
increased from 30±4 to 120±10*mmHg, and pH decreased from 7.43±0.02 to 6.76±0.10*.  
During asphyxia the arteriolar diameters were relatively unchanged, but there was a severe 
decrease in arteriolar flow velocity.  There was similar degree of severe cortical 
hypoperfusion shown by decreased low velocity over the parenchyma in accordance with the 
reduction of calculated arteriolar flow (Figure 14C and D).  
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Figure 14. Panel A: Pial arterioles showed no change to 2.1% hydrogen gas ventilation but 
dose-dependent vasodilation to hypercapnia.  NMDA also resulted in significant pial 
arteriolar dilation.  Arterioles were significantly constricted by both doses of NA but showed 
relatively no change to asphyxia.  Panel B: The flow velocity was determined using LASCA 
in the regions of interests over pial arterioles from speckle contrast images.  Hypercapnia 
elicited significant increase, in turn NA and asphyxia significant decrease in the velocity of 
flow in the pial arterioles.  Panel C: changes in arteriolar blood flow were calculated from the 
changes in pial arteriolar diameters and flow velocity, and plotted.  Panel D: The flow 
velocities in the regions of interests over parenchymal areas were determined as described for 
Panel B.  Flow velocity values indicate significant increases in parenchymal perfusion in 
response to hypercapnia and NMDA, but significant decreases in response to NA and 
asphyxia. p<0.05, * versus respective baselines before the stimulation, ** versus respective 
baseline values and smaller dose of respective stimulus. 
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Discussion 
There are several major findings of the study: 
1. The cerebrocortical microcirculation of newborn piglets is characterized by severe 
neurovascular dysfunction as late as 1 day after asphyxia shown by altered pial 
arteriolar responses both to endothelial and to neuronal-vascular stimuli. 
2. The studied pial arteriolar responses have been demonstrated to significantly 
contribute to determining local blood flow, since pial arteriolar vasodilation or 
vasoconstriction are reflected in respective increases or decreases in parenchymal 
perfusion proven by the novel LSI/LASCA method in our model. 
3. H2-supplemented ventilation can be applied safely to newborn pigs and per se does not 
affect baseline cerebrocortical blood flow, CR, neuronal activity (aEEG activity 
pattern) or microscopic morphology of the brain.  
4. Ventilation with gas containing H2 after asphyxia preserves neurovascular unit 
function both in the acute period and after 24h survival, it also protects the brain from 
A/R-induced early neuronal injury.  Furthermore, H2-ventilation keeps the vital 
parameters within physiological range, and cause faster recovery in brain electrical 
activity (aEEG).  These findings support the hypothesis that molecular H2 is 
neuroprotective in this large animal model of HIE. 
5. COX-2 expression is widespread in cortical neurons, however, its frequency is low or 
negligible in the subcortical brain regions in newborn pigs.  Cortical COX-2 
immunopositive neurons were approximately two times more numerous in the fronto-
parietal cortex as compared to the temporo-occipital region.  H2-supplemented 
ventilation similarly to asphyxia did not alter neuronal COX-2 expression after 4 hours 
of survival.  This pattern of COX-2 expression can affect the relative importance of 
COX-2 involvement in the pathophysiology of HIE in different cerebrocortical 
regions. 
 
The high burden on the society imposed by HIE-affected children necessitated the 
development of several animal models to help us understanding the pathophysiology of this 
disease.  Among the rodent and other big animal models, the newborn piglet has emerged as 
perhaps the most valuable large animal model.  This species has several advantages including 
similar brain developmental stage as that of 36-38 weeks human baby with comparable 
maturity of other body systems.  Its relatively large body size allows easy instrumentation and 
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monitoring of physiological variables.  Our laboratory has accumulated great experience with 
this species in the last 15 years.  Several colleagues have repeatedly shown that 
hypoxic/ischemic stress attenuates neurovascular reactivity that may result in severe neuronal 
damage [62, 69, 94, 106, 107].  However, the duration of these experiments did not allow the 
follow-up of the animals longer than 4-6 hours.  Furthermore, the available experimental 
instrumentation did not permit to focus on key issues required for long-term experiments: 
sterile catheters and surgical tools, pulsoximetry, rigorous core temperature control using 
servo-feedback, and multiple precision syringe pumps for appropriate administration of drugs 
and fluids – to name a few.  Since the neuronal damage leading to HIE is not limited only to 
the acute phase of reoxygenation period, but it further progresses in the subacute phase 
associating with the secondary energy failure developing approximately 12-24 hours after the 
hypoxic/ischemic stress [108], it was urgent to overcome the technical obstacles in order to be 
able to extend the survival time to at least 24 hours.  
The establishment of a longer-term survival animal model for the detection of delayed 
neurovascular and neural alterations following birth asphyxia has called for major changes.  
All the modifications made in the experimental protocol including the used drugs and 
equipments were in accordance with the protocols used currently in neonatal intensive care 
units following birth asphyxia [109].  In addition, surgery has been performed with sterile 
instruments to maintain aseptic conditions supplemented with intravenous administration of 
antibiotics to prevent infections during the survival time.  The catheterisation of the femoral 
artery was abandoned since it produced critical ischemia in the affected extremity over the 
elongated observation time.  In parallel to these changes, the monitoring of homeostatic 
parameters has been extended: in addition to the non-invasive measurement of blood pressure, 
and regular detection of blood gas parameters, we have now placed ECG electrodes for 
continuous ECG detection, pulsoximeter to monitor oxygen saturation, and blood glucose 
levels were also monitored.  These methodological innovations together made it possible to 
precisely regulate the fluid intake, the ventilation parameters, and to administer drugs 
achieving stable and satisfactory macrohemodynamic status. 
Another major improvement was the introduction of aEEG monitoring that provided 
valuable information on the severity of asphyxia and also on the gradual restoration of 
neuronal function. [109] [110].  The tight control of core temperature also mandated the 
reduction of asphyxia duration from the previously used 10 minutes to 8 minutes.  This was 
necessary because the mortality rate of the 10 min long asphyxia under the new experimental 
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conditions was unacceptably high in the pilot experiments.  Core temperature is well-known 
to affect the outcome of hypoxic-ischemic stress, and likely any undetected decrease in body 
temperature for instance during the asphyxia might have altered outcome due to the lack of a 
servo-controlled heating system.  
The major outcome measure of CR in our studies was the demonstration of pial arteriolar 
responses to various vasoactive stimuli.  In most common animal models and in humans as 
well, large cerebral arteries and pial arterioles have substantial tone and react to diverse 
vasodilator stimuli [111-113].  The contribution of pial arterioles to local vascular resistance 
is unequivocally accepted, however, the precise parenchymal flow changes in response to pial 
arteriolar vasodilatory or vasoconstrictor responses for a long time remained unknown.  There 
were efforts more than thirty years ago to determine cortical blood flow (CoBF) changes by 
simultaneously determining vascular cross sectional area and flow velocity in cats and dogs, 
however the procedure required quite difficult surgical procedure [114].  The cerebrovascular 
circulation has been demonstrated to be unique in that aspect that large cerebral arteries and 
arterioles on the surface of the brain account for as much as 50-60% of total cerebral vascular 
resistance.  Local intravascular pressure is approximately half of systemic blood pressure in 
the cerebrocortical pial arterioles at their entry into the parenchyma.  According to these 
findings, cerebral arteries and pial arterioles make major contributions to the regulation of 
cerebral blood flow and local microvascular perfusion pressure [115, 116].  
In the present studies, pial arteriolar diameters were determined using a relatively old 
technique: the implantation of a closed cranial window and measurement of internal vascular 
diameters with intravital microscopy.  This method has been scrupulously applied previously 
to demonstrate the selective vulnerability of certain responses to hypoxic/ischemic stress.  
Therefore, the alterations of CR to these vulnerable stimuli can be can be used as sensititive 
indicators of neurovascular unit dysfunction, and can also be utilized when assessing 
neuroprotective treatment strategies after hypoxic/ischemic stress [85, 94].  Our present 
studies focused at two of these vulnerable stimuli: hypercapnia- and the glutamate-receptor 
agonist NMDA-induced pial arteriolar vasodilation.  Furthermore, we assessed the effect of 
NA to study a major vasoconstrictor mechanism as well. 
Hypercapnia induced pial arteriolar vasodilation has been extensively studied in the piglet.  
10% CO2 ventilation dilate the arterioles by 40-50% that approximately doubles the arteriolar 
cross sectional area allowing similar increase in flow.  Some quantitative studies found that 
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CO2 ventilation increased cortical blood flow by ~300% in anesthetized or even awake piglets 
[117-119].  In contrast to studies using quantitative method for CBF measurement, in 
previous studies from our laboratory using Laser-Doppler flowmetry the data did not indicate 
such large increases in cortical blood flow; it increased only by ~40% at the same level of 
hypercapnia [106].  This difference shows significant uncertainty of the indirect LDF method 
highlighting the necessity of an accurate non-invasive method which can be simply applied. 
In our study performed with LASCA, we observed similar pial arteriolar dilation to previous 
studies, and the LASCA analysis of parenchymal regions of interest obtained during the same 
level of hypercapnia showed a ~250% increase in microvascular flow velocity.  Furthermore, 
we observed a significant increase in flow velocity in the dilated pial arterioles.  These data 
combined suggest that the calibre changes in pial arterioles have indeed profound effects on 
CoBF, suggesting that the true increases in CoBF to hypercapnia are likely even 
underestimated by taking the pial arteriolar dilation into account only.  Our LASCA studies, 
however, confirm that relevant conclusions concerning the effects of vascular reactivity 
changes on cortical perfusion can be drawn by studying pial arteriolar responses.  The 
development and testing of the LSI imager was simultaneous with our studies on delayed 
neurovascular unit dysfunction, so unfortunately we were unable to use this equipment in 
those experiments.  However, future studies definitely can yield important new data on the 
contribution of different cortical microvascular segments to the altered cerebrovascular 
regulation after asphyxia, observed in the present studies only in the pial microvessels.  
Hypercapnia-induced vasodilation is the most commonly used stimulus to test the CR and 
has been extensively studied in the piglet and other species. In newborn pigs, hypercapnia-
induced pial arteriolar dilation requires intact endothelium [84].  The response is associated 
with increase in cerebral synthesis of dilator prostanoids, and the prostanoids appear to be 
endothelial in origin [120].  Hypercapnia-induced vasodilation is vulnerable to 
hypoxia/ischemia, however supplementation of arachidonic acid restores the vasodilation 
[121].  Accordingly, hypoxia/ischemia seems to reduce the hypercapnia-induced vasodilation 
of pial arterioles through endothelial damage.  Although the majority of data suggest the main 
involvement of endothelium, the role of other cell types cannot be excluded, since other 
cellular components (neural/glial) can also contribute to hypercapnia-induced dilation in other 
experimental models [122, 123]. 
Glutamate is abundant in the mammalian nervous system and especially in the brain 
where it is the most abundant excitatory neurotransmitter, and also the precursor for GABA 
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the main inhibitory neurotransmitter [124].  Glutamate activates a number of ionotropic and 
metabotropic receptors on neurons and astrocytes.  Glutamate and its agonists elicit dose-
dependent vasodilation in the intact cerebral circulation when applied in vivo topically that 
was firstly shown in newborn pig [82, 85].  The vasoactive effects of glutamate are exerted 
via activation of any of the ionotropic receptors, however topical application to the brain 
surface of the cerebral cortex appears to dilate arterioles predominantly via NMDA receptor 
activation [125].  The activation of neuronal NMDA receptors leads to latter activation of a 
population of nNOS positive neurons and NO production via local neuronal connections.  The 
neuronally derived NO then diffuses to the vascular smooth muscle to increase in cGMP level 
and dilate the pial arterioles [61, 65, 86, 125].  
NMDA-induced vascular dilation was repeatable several times and even prolonged topical 
application did not appear to damage the cortex in vivo or affect pial responsiveness to other 
stimuli [68, 82, 126].  In contrast, NMDA-induced vasodilation has been shown to be 
vulnerable to periods of global cerebral hypoxia/ischemia [68].  Most of the studies strongly 
suggest the causative role of reactive oxygen species in attenuation of NMDA-induced pial 
arteriolar dilation after hypoxia/ischemia [127].  Topical application of ROS scavengers 
preserves cerebral arteriolar dilator responses to NMDA after hypoxia/ischemia in piglet [61].  
Cerebral resistance vessels have extensive sympathetic innervation, limiting 
cerebrovascular dilation during arterial hypertension, hypoxia, hypercapnia, and hemorrhagic 
states, attenuating disruption of BBB during hypertension, and contributing to development 
and maintenance of vascular morphology [68].  It appears that increase in sympathetic neural 
activity increases cerebral vascular tone and by interaction with the myogenic properties of 
the smooth muscle cells result in cerebral vasoconstriction and enhanced cerebral 
autoregulation [128].  Albeit it has been known that there are important differences among 
species in cerebrovascular responses to alpha-adrenergic stimuli, topical application of NA 
exerts near-maximal constriction in most of mammalian animals including newborn pigs 
[129, 130].  It has been also shown that there also are differences among species with respect 
to predominant alpha-adrenoreceptor subtypes in cerebral resistance vessels.  Alpha2-
adrenoreceptors predominate in pial arterioles of piglets, cats, dogs and cows [131-134].  
Sympathetic nerve stimulation also constricts cerebral arterioles via alpha2-adrenoreceptor 
subtype in piglet.  It has also been shown that exogenous NA also constricts pial arterioles via 
alpha2-adrenoreceptors [131, 135].  There are not just species but also age-related differences 
in action of exogenous NA, thus low concentrations of NA dilated cerebral arteries while 
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higher doses caused constriction in subadult pigs [136].  Similarly to the differences in 
different adrenoreceptor subtype densities there are striking differences in action of other 
common substances confirming the unique status of perinatal cerebrovascular physiology.  
For instance, the response of the newborn pig pial circulation to cholinergic stimulation is 
primarily constriction in contrast to well-known dilator response exerted in other vascular 
beds [137]. 
The different vasoactive stimuli allow the examination of components of neurovascular 
unit due to the different mechanisms of action and help understanding the pathophysiology of 
hypoxic/ischemic damages.  Hypercapnia-induced vasodilation requires intact endothelium 
confirmed by the observation that hypercapnia evokes cerebral vasodilation not only in vivo, 
but also in isolated, denervated vessels [138].  Based on these findings the function of 
neuronal and glial components in this vascular response seems to be minor, and 
hypoxia/ischemia appears to reduce hypercapnia-induced dilation of pial arterioles primarily 
through endothelial damage in piglets.  Asphyxia significantly attenuated CR to hypercapnia 
in the acute period of survival. H2-supplemented ventilation preserved CR to hypercapnia 1 
hour after A/R indicating intact endothelial function in the early reventilation period.  
Endothelial cells are critical not only to CR but also to the integrity of the blood-brain barrier; 
the latter being crucial to prevent ischemic brain damage [139].  The intact endothelial 
function in the early survival period may have further beneficial effects by protracting the 
near-normal function of the BBB. 
NMDA-induced vasodilation has been repeatedly shown to be sensitive to global cerebral 
ischemia/reperfusion, and CR to NMDA (100µM) is attenuated by 50% 1 h after 10 min 
ischemia [68, 85].  Interestingly, we have not observed a decrease in CR to NMDA 1 hour 
after 10 min of asphyxia.  The only study in the literature investigating the effect of asphyxia 
on NMDA-induced vasodilation reported “altered” CR to NMDA based on progressively 
increasing CR to NMDA in the early reventilation period [83].  However, in that study, CR to 
NMDA was not determined before asphyxia.  Furthermore, the vasodilation to 10µM NMDA 
used in that study corresponds with our later findings with this dose of NMDA under 
normoxic conditions [65].  Thus, it is conceivable that A/R represents a less severe stress in 
the acute period than global ischemia/reperfusion, and CR to 100µM NMDA does not change 
appreciably 4 hours following using this stress. 
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The study examining acute changes in CR has got several important limitations.  The 
changes in CR were demonstrated following only a short observational period that can be 
altered by development of reperfusion injury.  The cerebral metabolism may recover 
following the initial phase of energy failure and reperfusion, but can also deteriorate due to 
the secondary energy failure phase.  This phase starts usually within 6-24 hours after the 
initial insult and it results in progressive neuronal damage due to mitochondrial dysfunction 
and activation of apoptotic cascade.  The exact duration of this delayed phase cannot be 
precisely ascertained described period, although it seems to contribute to neuronal damage 
increase in the first 24-48 hours, and has a significant impact to neurodevelopmental outcome 
at 1 year and 4 years after insult [140].  The importance of this delayed period of secondary 
neuronal damage justified and necessitated the extension of the observation period to 24h in 
our subsequent studies. 
Previously, only two early studies reported decreased CR to hypercapnia and hypotension 
1 day after cerebral ischemia in newborn piglets [70, 81].  We are not aware of any other 
studies that so far assessed the delayed cerebral microvascular effects of this duration of 
hypoxic/ischemic stress.  However, the interpretation of these data is somewhat problematic 
for several reasons.  First, in these studies, 20 min of no flow global cerebral ischemia was 
induced in unanesthetized animals by elevating intracranial pressure above the arterial 
pressure by infusion of aCSF through a surgically previously implanted hollow bolt.  The 
clinical relevance of this long and complete selective brain ischemia is difficult to establish.  
Second, 30-60 min after the insult, the comatose piglets were allowed to breathe 
spontaneously and were fed with milk substitute by gavage, no analgesia or other supportive 
therapy was provided.  Blood pressure, tissue oxygenation and body temperature were not 
monitored and potential derangements in these parameters over the course of the 24h survival 
period could occur and contribute to the observed attenuation of CR.  Furthermore, 
confounding data emanated from a more recent set of studies, in which the attenuated CR to 
numerous stimuli (hypercapnia, NMDA, the ATP-sensitive potassium channel agonist 
aprikalim, and the prostacyclin analogue iloprost) spontaneously recovered 2-4 hours after 
hypoxic/ischemic stress [62, 63, 68].  In these studies, global cerebral ischemia was also 
performed with the same technique, however, in anesthetized animals and the duration of the 
anoxic stress was only 10 min.  The question whether the attenuation of CR lasts only 1-2 
hours or persists as long as 24 hours depending on the severity of the hypoxic/ischemic stress 
(10 vs. 20 min) or on the presence of anesthesia, remained unresolved. 
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In the 1-day survival animals a huge difference in CR between normoxic time controls 
and asphyxiated piglets were observed to hypercapnia and NMDA, and these differences 
could not be attributed to alterations in hemodynamics, blood chemistry or body temperature.  
Before the implantation of the closed cranial window for CR measurements, the anaesthesia 
was switched to α-chloralose in order to make the results comparable to acute changes.  
Indeed, the magnitude of pial arteriolar diameter changes in response to these stimuli was 
virtually identical to those determined in the acute model of brain asphyxia [65, 69, 141].  
Although both, the endothelium-dependent hypercapnia-induced vasodilation and the 
neuronal-vascular dependent NMDA-induced vasodilation were attenuated, thus, in contrast 
to the acute endothelial damage, the delayed impairment of CR was found to involve both the 
neuronal and the microvascular elements of the neurovascular unit vulnerable to hypoxic-
ischemic stress. 
The efficacy of early H2 administration to fully (hypercapnia) or at least partially 
(NMDA) preserve neurovascular function 1 day after the insult underscores the possibility 
that ROS-inflicted damages to the neurovascular unit in the early reventilation period trigger 
the development of delayed neurovascular dysfunction perhaps similar to the delayed energy 
failure observed also in this period.  A somewhat unexpected finding of the studies made on 
subacute piglet model of birth asphyxia was that the hypoxia/ischemia insensitive NA-
induced vasoconstriction [81] was significantly less in the H2 treated animals.  We are unsure 
if this slight difference has any biological significance, the little higher steady state pial 
arteriolar diameter values could perhaps be due to a better activation of compensatory 
vasodilatory mechanisms to prevent cortical hypoperfusion after asphyxia in these animals. 
To confirm the neuronal damage found by functional examination of the neurovascular 
unit quantitative neuropathologic examination was performed in numerous brain regions 
following both observational periods.  
This model of birth asphyxia showed significant difference to methods used previously 
describing significant neuronal changes [62, 68].  Not only the duration of the hypoxic period 
was 20% shorter, but in this model cortical blood flow was not abruptly and fully stopped, but 
more gradually decreased over the course of 4-5 min to ~20% of baseline values as 
determined previously with laser Doppler flowmetry [94].  Despite the shorter asphyxic 
period our observations made on the acute model of brain asphyxia showed remarkable 
neuronal damage following 10 minutes of asphyxia that can be significantly decreased by the 
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inhalation of H2-RA.  Our laboratory has previously shown the neurotoxic effect of 100% 
oxygen ventilation compared with RA ventilation after the same A/R stress used in this study 
[94].  The degree of neuronal injury was similar in the RA ventilated control groups in both 
studies, albeit in this study we used a quantitative cell counting approach in contrast to the 
semiquantitative scoring system used in the previous study.  Thus, our simple acute A/R 
model of perinatal asphyxia is capable to detect both neuroprotective and neurotoxic effects 
related to the changes in the composition of gas mixture used for ventilation.  We emphasize 
that we observed a beneficial effect of H2-RA ventilation in virtually all brain regions studied 
in the early survival period.  In our study was observed a mild decrease in CoBF during the 4 
hours of H2-RA ventilation that may also contribute to its early neuroprotective effect after 
A/R by limiting luxury oxygen delivery to the metabolically compromised brain parenchyma.  
Our observations made on the acute model of brain asphyxia were the first in demonstrating 
the early neuroprotective effect of H2-RA ventilation in a large animal model, however the 
observed early neuroprotective effect of H2-RA ventilation is in accordance with previous 
data reporting neuroprotection by 2.1% H2 gas in a neonatal rat hypoxia/ischemia model [100] 
and also in an adult rat stroke model [98].  
Compared to the study with acute survival period, in delayed study we used a milder 
hypoxic/ischemic insult: 8 min asphyxia.  Indeed, the recovery of the brain electrical activity 
on the aEEG and the mild neuronal damage detected with histopathology confirmed this 
notion.  We performed immunohistochemistry of the neuronal cytoskeletal protein 
microtubule associated protein (MAP-2) in order to determine the so called MAP-2 score 
established by Lingwood et al. [104]. MAP-2 is involved in maintaining the structural 
integrity of neuronal cytoskeleton.  Reduction in MAP-2 immunoreactivity is a sensitive early 
marker of neuronal injury and the labelling intensity correlates with severity of hypoxic insult 
and with the spatial distribution of the injury [142, 143].  In our study we detected no 
statistically significant differences among the groups also suggesting a relatively minor injury.  
The mild histological change concerning the number of damaged red neurons observed 24 
hours following 8 minutes of asphyxia is notably less than our results in acute survival study.  
This raises a question; whether all the red neurons counted 4 hours following 10 minutes of 
asphyxia displaying hyperchromatic cytoplasm, pyknotic nucleus and dramatic compaction 
are irreversibly damaged neurons, or they can belong to a much debated phenotype of 
so-called dark neurons.  Dark neurons can be produced by both in vivo, and post mortem 
mechanical injury, status epilepticus, hypoglycaemia and ischemia [144].  According to 
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electronmicroscopic observations, the ultrastructural elements of the dark neurons are intact, 
but are compacted, with increased electrodensity [145].  In our studies we could detect these 
electronmicroscopic changes in some of the cells in the acute survival groups.  Dark neurons 
may represent cell population at risk that may later recover after the restoration of blood 
supply and oxygenation [146].  This could explain how the number of hyperchromatic cells is 
reduced as the survival time increases in the temporal evolution of HIE.  
Birth asphyxia is characterized by systemic hypoxemia with hypercapnia.  The first 
compensatory response is the increase in CBF along with the redistribution of cardiac output 
to the essential vital organs.  During the reoxygenation period, free radical production 
increases due to enzymatic activation (e.g. cyclooxygenase, xanthine oxidase, lipoxygenase).  
After hypoxia/ischemia, COX-2-derived prostanoids and superoxide anions have been 
considered to enhance the neuronal and vascular damage in the CNS, but several studies 
showed that enhanced COX-2 expression could also be protective in the CNS [147].  COX-2 
produces superoxide anions in a 1:1 ratio with PGH2, and COX-derived ROS have been 
shown to be important for the generation of oxidative stress following ischemic stress [148, 
149].  Furthermore, COX-2 activity has been demonstrated to contribute to the neurovascular 
dysfunction after hypoxia/global cerebral ischemia in piglets. 
COX-2 is known to be induced by anoxic stress, parenchymal and cerebrovascular COX-2 
mRNA levels were shown to increase within 0.5–2 hours after global cerebral ischemia in the 
piglet [67, 150].  In our study made on acute changes after birth asphyxia, asphyxia was 
shown to significantly increase the number of damaged neurons after 4 hours, moreover, 
hydrogen ventilation was shown to partially alleviate the hypoxic/ischemic neuronal damage 
[141].  However, we could not show statistically significant increases of COX-2 
immunopositive neurons, perhaps there was a slight tendency for increased number of 
positive neurons after asphyxia in the parietal and occipital cortices.  This perhaps unexpected 
result is likely due to the increased turnover rate of COX-2, for instance in cerebral arteries 
COX-2 mRNA levels increased within 30 min, but increased protein levels were detected 
only 8 hours after ischemic stress [67].  According to the results of COX-2 
immunohistochemistry, the baseline pattern of cerebral COX-2 expression does not 
significantly change during the first few hours of reoxygenation - in the period when most 
oxidative stress occurs. 
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The role of COX-2 in the mechanism of hypoxic-ischemic injury in the piglet has been 
virtually exclusively derived from studies on the parietal cortex [64, 85, 148].  Our findings 
suggest that coincidentally the parietal cortex might be one of the most sensitive regions of 
the piglet brain to COX-2 inflicted neuronal injury, since COX-2 expression appears to be the 
most widespread in the neurons of this cortical region. First Dégi et al. [151] examined 
qualitatively the regional distribution of COX-2 immunoreactivity in the piglet brain, 
however, the cerebral cortex was only represented by samples from the parietal cortex, thus 
the regional difference discovered by our study could not be noted.  Our findings indicate that 
COX-2 dependent oxidative stress upon reoxygenation/reventilation after hypoxic/ischemic 
stress can be more severe in those cortical areas where basal COX-2 expression is 
significantly higher.  
Compared to the cortex, the hippocampus and the subcortical areas studied had low 
neuronal COX-2 expressions. Dégi et al. [151] reported qualitatively strong COX-2 
immunoreactivity in the stained hippocampal neurons, but in our study we found that the 
percentage of such stained neurons was in fact low.  Interestingly, neuronal COX-2 
expression appears to have an inverse relationship with regional cerebral blood flow.  Indeed, 
regional blood flow in the midbrain, pons, medulla and cerebellum (expressing low levels of 
COX-2) is significantly higher as compared to the cortical regions (displaying high COX-2 
expression) under normal conditions in piglets [152].  The cortical prostanoids appear to limit 
cortical blood flow by constricting cerebral arterioles, furthermore the high cortical COX-2 
expression appears to be necessary for the expression of prostanoid receptors and coupled 
signal transduction proteins required for the age-dependent vascular regulation [153, 154].  
We previously found that reactive hyperemia after asphyxia was significantly greater in the 
cerebellum than in the parietal cortex, and these hemodynamic differences were associated 
with increased vulnerability of the cerebellum but not the cortex to 100% O2 versus room air 
ventilation after asphyxia [94].  Our findings suggest that regional hemodynamic difference 
might exist within the cortex itself that need to be looked at. 
Despite the large number of ROS producing resource the antioxidant defences are 
immature in the neonate that further exacerbates the free radical damage.  Free radical and 
reactive oxygen species production can lead to lipid peroxidation, to DNA and protein 
damage, or can combine with nitric oxide to form peroxynitrite, which is a highly toxic 
oxidant [155, 156].  
48 
Oxidative stress induced by ROS produced during/after a hypoxic-ischemic episode is a 
widely accepted pathomechanism of perinatal brain injury [1, 157].  Thus, administration of 
antioxidant drugs either to decrease ROS production or to neutralize ROS seems to be a 
simple, straightforward approach to alleviate brain damage.  However, the antioxidant drug 
needs to be present at the ROS level surge in the early reventilation/reperfusion to exert its 
effect.  For example, the xanthine oxidase inhibitor allopurinol was found ineffective when 
administered to severely asphyxiated term infants 4 h after birth [158].  The authors 
speculated that drug administration was too late to successfully target the immediate ROS 
surge after resuscitation.  In fact, in a more recent study, the same research group has found 
that maternal treatment of in utero asphyxiated infants with allopurinol reduced the 
concentration of the brain injury marker S-100B in infants with therapeutic allopurinol levels 
[159].  It has been also shown that 95% of cord blood samples had target allopurinol 
concentrations at the moment of delivery [160].  Despite the advantages of maternal 
treatment, these types of drugs can be used only in suspected cases of fetal hypoxia. 
The development of an ideal gas mixture used for the resuscitation of infants affected by 
perinatal asphyxia may represent an ideal way to implement an instant neuroprotective 
therapy.  The importance of careful selection of inhaled oxygen concentration level is already 
well established, and the study confirms that addition of 2% H2 gas may likely confer 
neuroprotection by combating ROS-inflicted neuronal damage during the early 
reperfusion/reoxygenation period.  This concentration of H2 (2–2.1%) is safe because H2 has 
no risk of flammability below 4.7% in RA, and this H2-RA ventilation protocol yielded H2 
concentration of 20 ng/mL (10
-5
 M) in the arterial blood of adult rats, suggesting an effective 
antioxidant capacity at this dose [98].  Furthermore, other gases may potentially be added to 
the neuroprotective gas mixture to enhance neuronal survival and function.  The anesthetic 
gas, xenon (50% inhaled concentration) has been found to augment neuroprotection afforded 
by hypothermia in the neonatal rat hypoxia/ischemia model [161, 162], and helium (70% 
He/30% O2) provided excellent neuroprotection in adult rat stroke models [163-165].  
More recently, H2 ventilation has been found to protect against the development of 
cognitive impairment, cerebral palsy, and brain atrophy determined 1 month after germinal 
matrix haemorrhage induced in neonatal rats [166], and after subarachnoid hemmorhage in 
adults [167].  In our acute and subacute studies we demonstrated this neuroprotective effect in 
a large animal model.  We also showed the protective effect of H2 on CR in the early and the 
delayed reventilation period.  The whole range of the biological effects of H2 is not yet 
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known, and it may not be limited to ROS scavenging [168, 169], but the antioxidant potential 
of H2 plausibly explained the observed protection [141], because the mechanism of CR 
impairment involves ROS.  In the delayed birth asphyxia model H2 ventilation was given for 
4 hours starting immediately after the asphyxia and thus stopped 20 hours before the CR 
measurements excluding the possibility of the direct involvement of H2 on the observed 
preservation to CR. We believe that this H2 administration regimen would be also a clinically 
plausible therapy for asphyxiated infants: starting with the resuscitation and ending in a 
cooling centre where therapeutic hypothermia can be introduced (≤6 hours postnatally) [170], 
affording perhaps some extra neuroprotection.  
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